GLP3 Reta + Cagrilintide
Triple agonist + amylin analogue blend
“GLP3 Reta + Cagrilintide, 99% purity, for laboratory research use. A research blend of a GLP-1/GIP/glucagon triple-agonist peptide and a long-acting amylin-analogue peptide, investigated in vitro for incretin- and amylin-receptor activity.”
- Peptide research blend (triple-agonist + amylin analogue)
- ≥ 99%+ purity (HPLC)
- Store lyophilised at −20 °C, protect from light
- Pre-filled injection pen
For laboratory research use only. Not for human consumption, therapeutic use, diagnostic application, or veterinary use.
Certificate of Analysis (COA)1,250 AED
Independently third-party tested. Manufactured under sterile conditions with full endotoxin screening. COA available on request for every batch.
Research Use Only
This product is intended for laboratory research use only. It is not a drug, food, or cosmetic, and is not intended for human or animal use, diagnosis, treatment, cure, or prevention of any disease. By purchasing, you confirm you are a qualified researcher or institution acquiring this material for lawful research purposes.
Related Compounds
